Capital International Investors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$640M Sell
2,617,363
-4,853,668
-65% -$1.13B 0.15% 125
2025
Q4
$1.55B Buy
7,471,031
+3,605,981
+93% +$713M 0.24% 84
2025
Q3
$717M Buy
3,865,050
+3,266,354
+546% +$560M 0.12% 145
2025
Q2
$91.5M Sell
598,696
-3,101,458
-84% -$477M 0.02% 292
2025
Q1
$614M Sell
3,700,154
-1,375,544
-27% -$215M 0.12% 144
2024
Q4
$734M Buy
5,075,698
+5,148
+0.1% +$798K 0.14% 134
2024
Q3
$822M Buy
5,070,550
+937
+0% +$149K 0.16% 131
2024
Q2
$741M Sell
5,069,613
-12,086,268
-70% -$1.8B 0.15% 128
2024
Q1
$2.71B Sell
17,155,881
-11,829,795
-41% -$1.88B 0.55% 49
2023
Q4
$4.54B Sell
28,985,676
-543
-0% -$83.3K 1.02% 21
2023
Q3
$4.51B Buy
28,986,219
+1,160,424
+4% +$191M 1.15% 18
2023
Q2
$4.61B Buy
27,825,795
+10,724,110
+63% +$1.73B 1.11% 18
2023
Q1
$2.65B Sell
17,101,685
-467,969
-3% -$75.6M 0.68% 32
2022
Q4
$3.1B Sell
17,569,654
-1,212,751
-6% -$209M 0.83% 26
2022
Q3
$3.07B Sell
18,782,405
-728,840
-4% -$123M 0.9% 24
2022
Q2
$3.46B Sell
19,511,245
-521,705
-3% -$93M 0.94% 19
2022
Q1
$3.55B Sell
20,032,950
-173,269
-0.9% -$29.5M 0.81% 25
2021
Q4
$3.46B Sell
20,206,219
-365,411
-2% -$59.8M 0.73% 29
2021
Q3
$3.32B Buy
20,571,630
+1,417,008
+7% +$242M 0.76% 25
2021
Q2
$3.16B Buy
19,154,622
+868,659
+5% +$144M 0.72% 30
2021
Q1
$3.01B Buy
18,285,963
+13,703
+0.1% +$2.22M 0.76% 30
2020
Q4
$2.88B Buy
18,272,260
+11,904
+0.1% +$1.76M 0.78% 25
2020
Q3
$2.72B Buy
18,260,356
+17,262
+0.1% +$2.55M 0.84% 22
2020
Q2
$2.57B Buy
18,243,094
+1,516,129
+9% +$221M 0.84% 27
2020
Q1
$2.19B Buy
16,726,965
+2,004,688
+14% +$284M 0.9% 24
2019
Q4
$2.15B Sell
14,722,277
-4,898,022
-25% -$664M 0.73% 31
2019
Q3
$2.54B Sell
19,620,299
-2,375,078
-11% -$313M 0.97% 27
2019
Q2
$3.06B Sell
21,995,377
-610,880
-3% -$84.6M 1.22% 18
2019
Q1
$3.16B Sell
22,606,257
-2,417,554
-10% -$324M 1.36% 11
2018
Q4
$3.23B Buy
25,023,811
+39,562
+0.2% +$5.52M 1.61% 11
2018
Q3
$3.45B Buy
24,984,249
+18,768,905
+302% +$2.49B 1.58% 10
2018
Q2
$754M Buy
6,215,344
+142
+0% +$17.7K 0.85% 38
2018
Q1
$796M Buy
6,215,202
+96,999
+2% +$13.1M 0.92% 33
2017
Q4
$855M Buy
6,118,203
+641,400
+12% +$89.3M 0.97% 28
2017
Q3
$712M Buy
5,476,803
+585,201
+12% +$77.6M 0.85% 30
2017
Q2
$647M Buy
4,891,602
+286,100
+6% +$36.5M 0.86% 31
2017
Q1
$574M Buy
4,605,502
+132,300
+3% +$15.8M 0.78% 39
2016
Q4
$515M Buy
4,473,202
+1,386,700
+45% +$160M 0.74% 42
2016
Q3
$365M Buy
3,086,502
+1,209,302
+64% +$147M 0.53% 54
2016
Q2
$228M Buy
+1,877,200
New +$213M 0.33% 93
2013
Q3
Sell
-200,000
Closed -$17.2M 198
2013
Q2
$17.2M Buy
+200,000
New +$17M 0.08% 174

Other funds holding JNJ

Capital International Investors's JNJ Position: Q1 2026 in Review

Capital International Investors reduced its Johnson & Johnson (JNJ) stake by 65% in Q1 2026, selling an estimated $1.13B and leaving 2,617,363 shares worth $640M. The position accounts for 0.15% of the portfolio, ranked #125.

Capital International Investors first reported a position in JNJ in Q2 2013 and has held it in 41 quarters since. The position peaked at $4.61B in Q2 2023. 4,622 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Capital International Investors held 2,617,363 shares of Johnson & Johnson worth $640M as of Q1 2026.
  • Capital International Investors sold 4,853,668 Johnson & Johnson shares in Q1 2026, an estimated $1.13B.
  • Johnson & Johnson made up 0.15% of Capital International Investors's portfolio in Q1 2026, its #125 holding.
  • Capital International Investors first reported a position in Johnson & Johnson in Q2 2013 and has held it in 41 quarters since.
  • Capital International Investors's Johnson & Johnson position peaked at $4.61B in Q2 2023.
  • 4,622 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Capital International Investors's 13F filing for Q1 2026, filed 13 May 2026.